Key insights and market outlook
Perspirex, a Danish antiperspirant brand, has returned to the Indonesian market after a period of absence due to a distributor change. PT Bintang Inter Global has been appointed as the new official distributor by Orkla Health, ensuring continued availability of various Perspirex products. The brand's return is seen as positive momentum for Denmark-Indonesia trade relations, marking 75 years of diplomatic ties.
Perspirex, a well-known Danish antiperspirant brand owned by Orkla Health, has clarified that its temporary absence from the Indonesian market was due to a distributor change, not a complete exit. CEO of PT Bintang Inter Global, Herman The, explained that the company has been appointed as the new official distributor, ensuring the brand's continued presence in Indonesia.
The new distribution arrangement is designed to enhance market penetration and product availability. Herman The emphasized that Perspirex never left the Indonesian market, stating, "It's just a change of distributor, nothing else." The brand is now available in various formulations including Original, Comfort, Strong, For Regular, and For Maximum, all featuring a skin care system to minimize irritation.
To improve market reach, PT Bintang Inter Global is expanding distribution channels to make Perspirex products more accessible to consumers. This includes availability in both online and offline retail platforms. The company is also introducing additional products such as Hand & Foot Lotion for consumers experiencing sweaty palms.
The return of Perspirex has been welcomed by the Danish Embassy as a positive development for Denmark-Indonesia trade relations. Commercial Counsellor Morten Kruse noted that the enthusiasm for Danish products aligns with the strengthening economic ties between the two nations, particularly as they celebrate 75 years of diplomatic relations this year.
Herman The reassured that Perspirex remains a global brand with a continued presence in Indonesia. The brand's products are backed by Orkla Group's rigorous research and quality standards, maintaining their reputation for effectiveness and safety. The return demonstrates Orkla Health's commitment to the Indonesian market through its new distribution partnership.
Distributor Change
Brand Re-entry
Trade Relations Enhancement